5:20 PM
 | 
Jan 12, 2012
 |  BC Extra  |  Company News

Covance in R&D deal with Inserm

CRO Covance Inc. (NYSE:CVD) signed a four-year R&D deal with the technology transfer and seed investment arms of the French...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >